These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25520877)

  • 1. MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma.
    Yu L; Zhou L; Cheng Y; Sun L; Fan J; Liang J; Guo M; Liu N; Zhu L
    Am J Cancer Res; 2014; 4(6):897-906. PubMed ID: 25520877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
    Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
    Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.
    Yang Y; Li M; Chang S; Wang L; Song T; Gao L; Hu L; Li Z; Liu L; Yao J; Huang C
    Mol Med Rep; 2014 Nov; 10(5):2643-8. PubMed ID: 25174704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
    Qin AD; Liu XX; Li J; Liu J; Li YS
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
    [No Abstract]   [Full Text] [Related]  

  • 6. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
    BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6.
    Min P; Li W; Zeng D; Ma Y; Xu D; Zheng W; Tang F; Chen J; Shi J; Hu H; Wang J; Yang D; Liu J; Zhang J; Zhang M
    Bull Cancer; 2017 Apr; 104(4):311-320. PubMed ID: 28081866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma.
    Tian J; Hu X; Gao W; Zhang J; Chen M; Zhang X; Ma J; Yuan H
    Am J Transl Res; 2016; 8(6):2575-84. PubMed ID: 27398141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.
    Li X; Zhang W; Zhou L; Yue D; Su X
    Int J Clin Exp Pathol; 2015; 8(10):12455-63. PubMed ID: 26722432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q; Zhang W; Wang Z; Liu S
    BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
    Zhao J; Xu T; Wang F; Cai W; Chen L
    Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
    Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
    Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
    Zhang W; Lu Z; Gao Y; Ye L; Song T; Zhang X
    Biochem Biophys Res Commun; 2015 May; 460(3):793-8. PubMed ID: 25824049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-32 Regulates Development and Progression of Hepatocellular Carcinoma by Targeting ADAMTS9 and Affects Its Prognosis.
    Li S; Li T; Li X; Yao Y; Jiang X; Zhao L; Guo W
    Med Sci Monit Basic Res; 2018 Nov; 24():177-187. PubMed ID: 30393368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
    Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X
    Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma.
    Yu L; Gong X; Sun L; Yao H; Lu B; Zhu L
    Oncotarget; 2015 Nov; 6(36):39225-34. PubMed ID: 26287602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells.
    Zhang X; Hu S; Zhang X; Wang L; Zhang X; Yan B; Zhao J; Yang A; Zhang R
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1078-84. PubMed ID: 24370822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.